RxDoctor Payments DataLook up a doctor →

TISSUEBLUE: payments to doctors

Payments that named TISSUEBLUE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$298K
Providers
540
Transactions
989
Average per transaction
$301

The per-transaction average — $301 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 540 providers the average total is $552, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Dutch Ophthalmic, USA$272,23791.4%
Dutch Ophthalmic Research Center (international) B.v.$25,7578.6%
← All drugs & devices